Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,889,949
-
Share change
-
-508,857
-
Total reported value
-
$2,301,880
-
Price per share
-
$1.22
-
Number of holders
-
12
-
Value change
-
-$641,307
-
Number of buys
-
5
-
Number of sells
-
9
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q3 2020
As of 30 Sep 2020,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,889,949 shares.
The largest 10 holders included
MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, MACQUARIE GROUP LTD, Virtu Financial LLC, WEDBUSH SECURITIES INC, ADVISOR GROUP HOLDINGS, INC., Phoenix Holdings Ltd., RAYMOND JAMES & ASSOCIATES, GEODE CAPITAL MANAGEMENT, LLC, and Vident Investment Advisory, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.